awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26738359-6AE09D99-0A93-41DC-B54F-376155022F2C
Q26738359-6AE09D99-0A93-41DC-B54F-376155022F2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738359-6AE09D99-0A93-41DC-B54F-376155022F2C
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment
P2860
Q26738359-6AE09D99-0A93-41DC-B54F-376155022F2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738359-6AE09D99-0A93-41DC-B54F-376155022F2C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4b3e29d040ac29e3b0bc9770f650fbf6156625fe
P2860
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.